Masonic Cancer Center

A Comprehensive Cancer Center designated by the National Cancer Institute

Find a Clinical Trial

Quick Search (by title or disease)
  

Go to Advanced Search for more options.

Clinical Trials Help
Contact our Cancer Information Line nurse with your questions about open or upcoming clinical trials, second opinions, or patient referrals.
ccinfo@umn.edu • 612-624-2620 • 1-888-226-2376

Kidney (Renal Cell) cancer Clinical Trials

Protocol Number Title
2001LS058
MT2001-10 Allogeneic Bone Marrow Transplant Using Less Intensive Therapy
2007NT091
COG AREN03B2: Renal Tumors Classification, Biology and Banking Study.
2009NTUC056
Childhood Cancer Survivor Study
2011CG020
CALGB 90601 A Randomized Double-Blind Phase III Study Comparing Gemcitabine,Cisplatin and Bevacizumab to Gemcitabine Cisplatin and Placebo in Patients with Advanced Transitional Cell carcinoma
2011IS155
A RANDOMIZED, PLACEBO-CONTROLLED, MULTI-SITE PHASE 2 STUDY EVALUATING THE SAFETY AND EFFICACY OF PREEMPTIVE TREATMENT WITH CMX001 FOR THE PREVENTION OF ADENOVIRUS DISEASE FOLLOWING HEMATOPOIETIC STEM CELL TRANSPLANTATION (THE ADV HALT TRIAL)
2011NTIS086
Proleukin Observational Registry to Evaluate the Treatment Patterns and Clinical Response in Malignancy (PROCLAIM)
2012CG003
CITN 11-02: A phase 1 study of recombinant human IL15 (rhIL15) in adults with advanced solid tumors
2012IS062
An International Phase 3 Randomized Trial of Autologous Dendritic Cell Immunotherapy (AGS-003) Plus Standard Treatment of Advanced Renal Cell Carcinoma (ADAPT)
2013IS044
An open-label, parallel-group, multicenter phase I study to investigate the pharmacokinetics of NKTR-102 for injection (Etirinotecan pegol) in patients with advanced or metastatic solid tumors and mild or moderate hepatic impairment (Nektar 12-102-13)

9 trials displayed

  • ©2013 Regents of the University of Minnesota. All rights reserved.
  • The University of Minnesota is an equal opportunity educator and employer
  • Last modified on